BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35047842)

  • 1. Biallelic variants in
    Tran TT; Keller RB; Guillemyn B; Pepin M; Corteville JE; Khatib S; Fallah MS; Zeinali S; Malfait F; Symoens S; Coucke P; Witters P; Levtchenko E; Bagherian H; Nickerson DA; Bamshad MJ; Chong JX; ; Byers PH
    HGG Adv; 2021 Oct; 2(4):100051. PubMed ID: 35047842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta.
    Moosa S; Yamamoto GL; Garbes L; Keupp K; Beleza-Meireles A; Moreno CA; Valadares ER; de Sousa SB; Maia S; Saraiva J; Honjo RS; Kim CA; Cabral de Menezes H; Lausch E; Lorini PV; Lamounier A; Carniero TCB; Giunta C; Rohrbach M; Janner M; Semler O; Beleggia F; Li Y; Yigit G; Reintjes N; Altmüller J; Nürnberg P; Cavalcanti DP; Zabel B; Warman ML; Bertola DR; Wollnik B; Netzer C
    Am J Hum Genet; 2019 Oct; 105(4):836-843. PubMed ID: 31564437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound Heterozygous Frameshift Mutations in MESD Cause a Lethal Syndrome Suggestive of Osteogenesis Imperfecta Type XX.
    Stürznickel J; Jähn-Rickert K; Zustin J; Hennig F; Delsmann MM; Schoner K; Rehder H; Kreczy A; Schinke T; Amling M; Kornak U; Oheim R
    J Bone Miner Res; 2021 Jun; 36(6):1077-1087. PubMed ID: 33596325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants.
    Tüysüz B; Elkanova L; Uludağ Alkaya D; Güleç Ç; Toksoy G; Güneş N; Yazan H; Bayhan AI; Yıldırım T; Yeşil G; Uyguner ZO
    Bone; 2022 Feb; 155():116293. PubMed ID: 34902613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant MESD links cellular stress to type I collagen aggregation in osteogenesis imperfecta type XX.
    Ghosh DK; Udupa P; Shrikondawar AN; Bhavani GS; Shah H; Ranjan A; Girisha KM
    Matrix Biol; 2023 Jan; 115():81-106. PubMed ID: 36526215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up findings in a Turkish girl with osteogenesis imperfecta type XX caused by a homozygous MESD variant.
    Uludağ Alkaya D; Uyguner ZO; Güneş N; Tüysüz B
    Am J Med Genet A; 2022 May; 188(5):1639-1646. PubMed ID: 35092157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Variation in Vietnamese Osteogenesis Imperfecta Patients Sharing a Recessive
    Zhytnik L; Duy BH; Eekhoff M; Wisse L; Pals G; Reimann E; Kõks S; Märtson A; Maugeri A; Maasalu K; Micha D
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
    Lu W; Liu CC; Thottassery JV; Bu G; Li Y
    Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.
    Lin C; Lu W; Zhang W; Londoño-Joshi AI; Buchsbaum DJ; Bu G; Li Y
    PLoS One; 2013; 8(2):e58102. PubMed ID: 23469146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.
    Ohata Y; Takeyari S; Nakano Y; Kitaoka T; Nakayama H; Bizaoui V; Yamamoto K; Miyata K; Yamamoto K; Fujiwara M; Kubota T; Michigami T; Yamamoto K; Yamamoto T; Namba N; Ebina K; Yoshikawa H; Ozono K
    Osteoporos Int; 2019 Nov; 30(11):2333-2342. PubMed ID: 31363794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.
    Fiscaletti M; Biggin A; Bennetts B; Wong K; Briody J; Pacey V; Birman C; Munns CF
    Bone; 2018 May; 110():66-75. PubMed ID: 29382611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
    Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
    Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding.
    Li Y; Chen J; Lu W; McCormick LM; Wang J; Bu G
    J Cell Sci; 2005 Nov; 118(Pt 22):5305-14. PubMed ID: 16263759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta.
    Zhang H; Yue H; Wang C; Hu W; Gu J; He J; Fu W; Hu Y; Li M; Zhang Z
    Mol Med Rep; 2016 Nov; 14(5):4918-4926. PubMed ID: 27748872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in COL1A1/A2 and CREB3L1 are associated with oligodontia in osteogenesis imperfecta.
    Andersson K; Malmgren B; Åström E; Nordgren A; Taylan F; Dahllöf G
    Orphanet J Rare Dis; 2020 Mar; 15(1):80. PubMed ID: 32234057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity.
    Hsieh JC; Lee L; Zhang L; Wefer S; Brown K; DeRossi C; Wines ME; Rosenquist T; Holdener BC
    Cell; 2003 Feb; 112(3):355-67. PubMed ID: 12581525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta.
    Alanay Y; Avaygan H; Camacho N; Utine GE; Boduroglu K; Aktas D; Alikasifoglu M; Tuncbilek E; Orhan D; Bakar FT; Zabel B; Superti-Furga A; Bruckner-Tuderman L; Curry CJ; Pyott S; Byers PH; Eyre DR; Baldridge D; Lee B; Merrill AE; Davis EC; Cohn DH; Akarsu N; Krakow D
    Am J Hum Genet; 2010 Apr; 86(4):551-9. PubMed ID: 20362275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian bone fragility disorders.
    Robinson ME; Rauch F
    Bone; 2019 Sep; 126():11-17. PubMed ID: 31039433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family with homozygous and heterozygous p.Gly337Ser mutations in COL1A2.
    Udomchaiprasertkul W; Kuptanon C; Porntaveetus T; Shotelersuk V
    Eur J Med Genet; 2020 Jun; 63(6):103896. PubMed ID: 32081708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.
    Wang JY; Liu Y; Song LJ; Lv F; Xu XJ; San A; Wang J; Yang HM; Yang ZY; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    Calcif Tissue Int; 2017 Jan; 100(1):55-66. PubMed ID: 27796462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.